Nanox Partners with French Radiology Group Olympe Imagerie to Advance Clinical Validation in Europe

Core Insights - Nanox Imaging Ltd has announced a collaboration with Olympe Imagerie to deploy the Nanox.ARC system at Hospital Privé Jacques Cartier MASSY for lung cancer screening applications, marking a significant step in its European expansion strategy [1][2][5] Company Overview - Nanox is focused on transforming healthcare through affordable medical imaging technologies, leveraging advanced AI and proprietary digital X-ray sources [6] - The Nanox.ARC system is a multi-source digital tomosynthesis system that offers enhanced diagnostic capabilities at a lower cost compared to traditional imaging systems [3] Collaboration Details - The Nanox.ARC system will be utilized in clinical trials at Hospital Privé Jacques Cartier MASSY to evaluate its effectiveness in lung cancer detection and management [2][5] - Olympe Imagerie serves over 400,000 patients annually across multiple centers in the Ile-de-France region, indicating a substantial patient base for the deployment of the Nanox.ARC [4] Market Strategy - France is identified as a key market for Nanox's European expansion, with the collaboration aimed at advancing clinical validation efforts in this region [5] - The deployment of the Nanox.ARC is expected to enhance early detection of lung abnormalities, which is crucial for improving patient outcomes in lung cancer screening [5]